Brokerages Anticipate Colgate-Palmolive (CL) Will Post Quarterly Sales of $3.91 Billion

Wall Street analysts expect Colgate-Palmolive (NYSE:CL) to report $3.91 billion in sales for the current quarter, according to Zacks Investment Research. Seven analysts have issued estimates for Colgate-Palmolive’s earnings. The lowest sales estimate is $3.82 billion and the highest is $4.00 billion. Colgate-Palmolive posted sales of $3.72 billion in the same quarter last year, which would indicate a positive year over year growth rate of 5.1%. The firm is expected to report its next earnings results on Friday, January 26th.

According to Zacks, analysts expect that Colgate-Palmolive will report full year sales of $3.91 billion for the current year, with estimates ranging from $15.33 billion to $15.56 billion. For the next year, analysts forecast that the firm will report sales of $16.07 billion per share, with estimates ranging from $15.94 billion to $16.27 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that cover Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The business had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same period in the previous year, the company posted $0.73 earnings per share. The business’s revenue for the quarter was up 2.8% on a year-over-year basis.

Several equities research analysts recently commented on CL shares. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Saturday, November 25th. Jefferies Group reiterated a “hold” rating and set a $79.00 target price on shares of Colgate-Palmolive in a report on Thursday, September 28th. Societe Generale lowered Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 target price for the company. in a research report on Wednesday. They noted that the move was a valuation call. Zacks Investment Research lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Finally, Macquarie started coverage on Colgate-Palmolive in a report on Thursday, September 14th. They issued a “neutral” rating and a $76.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and four have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $76.04.

In related news, CMO Mukul Deoras sold 7,500 shares of the business’s stock in a transaction on Friday, November 10th. The shares were sold at an average price of $73.28, for a total value of $549,600.00. Following the sale, the chief marketing officer now owns 45,217 shares of the company’s stock, valued at $3,313,501.76. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Victoria L. Dolan sold 9,000 shares of the business’s stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total transaction of $660,690.00. The disclosure for this sale can be found here. Insiders sold 173,673 shares of company stock worth $12,629,293 over the last three months. 1.02% of the stock is currently owned by insiders.

Institutional investors and hedge funds have recently bought and sold shares of the stock. American Beacon Advisors Inc. acquired a new position in shares of Colgate-Palmolive in the 1st quarter valued at $102,000. Jacobi Capital Management LLC grew its stake in shares of Colgate-Palmolive by 125.5% during the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after buying an additional 803 shares during the last quarter. Proficio Capital Partners LLC grew its stake in shares of Colgate-Palmolive by 16.9% in the first quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock worth $107,000 after purchasing an additional 207 shares during the last quarter. OLD Second National Bank of Aurora purchased a new position in Colgate-Palmolive in the second quarter worth about $109,000. Finally, Krilogy Financial LLC grew its stake in Colgate-Palmolive by 23.0% in the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after acquiring an additional 289 shares during the period. Institutional investors own 73.22% of the company’s stock.

Shares of Colgate-Palmolive (NYSE:CL) opened at $72.45 on Friday. Colgate-Palmolive has a 52 week low of $63.43 and a 52 week high of $77.27. The company has a market capitalization of $63,890.94, a P/E ratio of 25.35, a PEG ratio of 3.33 and a beta of 0.80. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd were given a $0.40 dividend. The ex-dividend date of this dividend was Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.21%. Colgate-Palmolive’s payout ratio is 61.78%.

TRADEMARK VIOLATION NOTICE: “Brokerages Anticipate Colgate-Palmolive (CL) Will Post Quarterly Sales of $3.91 Billion” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of international trademark & copyright law. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/12/01/brokerages-anticipate-colgate-palmolive-cl-will-post-quarterly-sales-of-3-91-billion.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply